Last updated: 2026-09-16 10:31:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Personalis, Inc. (PSNL) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $15,69, with a market capitalisation of $1,74B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4,96 to $18,89. This page covers its latest market performance, valuation, price trends and company information.
$1,74B | |
$16,16 | |
$53,46 | |
$0,89 | |
$16,10 | |
2,00 | |
4,06M | |
-- | |
$18,89 | |
$4,96 | |
-- | |
-- |
Personalis, Inc. (PSNL) is trading at $15,69 in pre-market trading as of 2026-09-16 09:30:00, down 2,54% ($0,41) from the previous close of $16,10
Pre-market trading shows how investors are pricing PSNL before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, Personalis, Inc. (PSNL) moved from $17,20 to $15,69, representing a decline of 8,77% ($1,51).
The stock traded between $15,69 and $17,35 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 2,24 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 77,0%
PSNL is currently trading at $15,69, placing it 77,0% of the way from its 52-week low of $4,96 to its 52-week high of $18,89. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 260 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Personalis, Inc. (PSNL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.